Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$23.93 +0.27 (+1.14%)
As of: Sep 4, 2026 · 3:17 PM EDT

Arcutis Biotherapeutics (ARQT) Shares Outstanding (Entity) (2019 - 2026)

Analysis

Arcutis Biotherapeutics (ARQT) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 214.24 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 575.00 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
10 Arcutis Biotherapeutics 3.13 Bn 2.89 Bn 118.92 Mn 125.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125.59 Mn
Mar 31, 2026 125.04 Mn
Dec 31, 2025 123.33 Mn
Sep 30, 2025 120.29 Mn
Jun 30, 2025 119.80 Mn
Mar 31, 2025 119.14 Mn
Dec 31, 2024 117.85 Mn
Sep 30, 2024 117.00 Mn
Jun 30, 2024 116.48 Mn
Mar 31, 2024 115.51 Mn
Dec 31, 2023 69.31 Mn
Sep 30, 2023 61.86 Mn
Jun 30, 2023 61.63 Mn
Mar 31, 2023 61.36 Mn
Dec 31, 2022 61.04 Mn
Sep 30, 2022 60.91 Mn
Jun 30, 2022 51.53 Mn
Mar 31, 2022 51.36 Mn
Dec 31, 2021 50.26 Mn
Sep 30, 2021 50.13 Mn